{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:13:40Z","timestamp":1791335620814,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was supported by the National Natural Science Foundation of China","award":["82072577"],"award-info":[{"award-number":["82072577"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13258-025-01667-2","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:44:55Z","timestamp":1756122295000},"page":"1049-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics integration reveals CYTL1 and H6PD as key regulators of tumor metabolism in mesothelioma"],"prefix":"10.1007","volume":"47","author":[{"given":"Jiao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanxue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"2","key":"1667_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20(2):163\u2013172","journal-title":"Nat Immunol"},{"issue":"5","key":"1667_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","volume":"9","author":"L Arpinati","year":"2023","unstructured":"Arpinati L, Scherz-Shouval R (2023) From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer 9(5):421\u2013443","journal-title":"Trends Cancer"},{"issue":"159","key":"1667_CR3","doi-asserted-by":"publisher","first-page":"200226","DOI":"10.1183\/16000617.0226-2020","volume":"30","author":"R Asciak","year":"2021","unstructured":"Asciak R, George V, Rahman NM (2021) Update on biology and management of mesothelioma. Eur Respir Rev 30(159):200226","journal-title":"Eur Respir Rev"},{"issue":"24","key":"1667_CR4","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.3390\/cancers15245731","volume":"15","author":"FR Bertuccio","year":"2023","unstructured":"Bertuccio FR, Agustoni F, Galli G, Bortolotto C, Saddi J et al (2023) Pleural mesothelioma: treatable traits of a heterogeneous disease. Cancers (Basel) 15(24):5731","journal-title":"Cancers (Basel)"},{"issue":"22","key":"1667_CR5","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1002\/cncr.26143","volume":"117","author":"BM Burt","year":"2011","unstructured":"Burt BM, Rodig SJ, Tilleman TR, Elbardissi AW, Bueno R et al (2011) Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer 117(22):5234\u20135244","journal-title":"Cancer"},{"issue":"5","key":"1667_CR6","first-page":"402","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F et al (2019) Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin 69(5):402\u2013429","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1667_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G et al (2023) Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet 55(1):44\u201353","journal-title":"Nat Genet"},{"issue":"1","key":"1667_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13395-019-0216-z","volume":"10","author":"CL Doig","year":"2020","unstructured":"Doig CL, Zielinska AE, Fletcher RS, Oakey LA, Elhassan YS et al (2020) Induction of the nicotinamide riboside kinase NAD(+) salvage pathway in a model of sarcoplasmic reticulum dysfunction. Skelet Muscle 10(1):5","journal-title":"Skelet Muscle"},{"issue":"12","key":"1667_CR9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53(12):1712\u20131721","journal-title":"Nat Genet"},{"issue":"383","key":"1667_CR10","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T et al (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383):eaag1166","journal-title":"Sci Transl Med"},{"issue":"4","key":"1667_CR11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","volume":"12","author":"Z Guo","year":"2017","unstructured":"Guo Z, Carbone M, Zhang X, Su D, Sun W et al (2017) Improving the accuracy of mesothelioma diagnosis in China. J Thorac Oncol 12(4):714\u2013723","journal-title":"J Thorac Oncol"},{"issue":"9","key":"1667_CR12","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ajhg.2022.07.012","volume":"109","author":"SC Hanks","year":"2022","unstructured":"Hanks SC, Forer L, Schonherr S, LeFaive J, Martins T et al (2022) Extent to which array genotyping and imputation with large reference panels approximate deep whole-genome sequencing. Am J Hum Genet 109(9):1653\u20131666","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1667_CR13","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1158\/2159-8290.CD-22-1467","volume":"13","author":"WH Hsu","year":"2023","unstructured":"Hsu WH, LaBella KA, Lin Y, Xu P, Lee R et al (2023) Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression. Cancer Discov 13(12):2652\u20132673","journal-title":"Cancer Discov"},{"issue":"1","key":"1667_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12885-024-12551-9","volume":"24","author":"J Huang","year":"2024","unstructured":"Huang J, Sun J, Wang K, Zheng L, Fan Y et al (2024) Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study. BMC Cancer 24(1):774","journal-title":"BMC Cancer"},{"issue":"2","key":"1667_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41379-019-0330-9","volume":"33","author":"YP Hung","year":"2020","unstructured":"Hung YP, Dong F, Dubuc AM, Dal Cin P, Bueno R et al (2020) Molecular characterization of localized pleural mesothelioma. Mod Pathol 33(2):271\u2013280","journal-title":"Mod Pathol"},{"issue":"2","key":"1667_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12307-012-0100-4","volume":"5","author":"DJ Ireland","year":"2012","unstructured":"Ireland DJ, Kissick HT, Beilharz MW (2012) The role of regulatory T cells in mesothelioma. Cancer Microenviron 5(2):165\u2013172","journal-title":"Cancer Microenviron"},{"issue":"13","key":"1667_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","volume":"385","author":"SM Janes","year":"2021","unstructured":"Janes SM, Alrifai D, Fennell DA (2021) Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med 385(13):1207\u20131218","journal-title":"N Engl J Med"},{"issue":"7944","key":"1667_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518","journal-title":"Nature"},{"key":"1667_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.matbio.2024.06.004","volume":"132","author":"P Li","year":"2024","unstructured":"Li P, Zhang H, Chen T, Zhou Y, Yang J et al (2024) Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer. Matrix Biol 132:59\u201371","journal-title":"Matrix Biol"},{"issue":"6","key":"1667_CR20","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22(6):bbab260","journal-title":"Brief Bioinform"},{"issue":"1","key":"1667_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20(1):131","journal-title":"Mol Cancer"},{"issue":"21","key":"1667_CR22","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1111\/febs.14642","volume":"285","author":"P Marbet","year":"2018","unstructured":"Marbet P, Klusonova P, Birk J, Kratschmar DV, Odermatt A (2018) Absence of hexose-6-phosphate dehydrogenase results in reduced overall glucose consumption but does not prevent 11beta-hydroxysteroid dehydrogenase-1-dependent glucocorticoid activation. FEBS J 285(21):3993\u20134004","journal-title":"FEBS J"},{"issue":"1\u20132","key":"1667_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humimm.2005.11.005","volume":"67","author":"F Meloni","year":"2006","unstructured":"Meloni F, Morosini M, Solari N, Passadore I, Nascimbene C et al (2006) Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 67(1\u20132):1\u201312","journal-title":"Hum Immunol"},{"issue":"8","key":"1667_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41416-021-01462-2","volume":"125","author":"J Obacz","year":"2021","unstructured":"Obacz J, Yung H, Shamseddin M, Linnane E, Liu X et al (2021) Biological basis for novel mesothelioma therapies. Br J Cancer 125(8):1039\u20131055","journal-title":"Br J Cancer"},{"issue":"10","key":"1667_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orru","year":"2020","unstructured":"Orru V, Steri M, Sidore C, Marongiu M, Serra V et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036\u20131045","journal-title":"Nat Genet"},{"issue":"10197","key":"1667_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","volume":"394","author":"DM Roden","year":"2019","unstructured":"Roden DM, McLeod HL, Relling MV, Williams MS, Mensah GA et al (2019) Pharmacogenomics Lancet 394(10197):521\u2013532","journal-title":"Pharmacogenomics Lancet"},{"issue":"4","key":"1667_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1124\/pharmrev.122.000810","volume":"75","author":"W Sadee","year":"2023","unstructured":"Sadee W, Wang D, Hartmann K, Toland AE (2023) Pharmacogenomics: Driving Personalized Medicine. Pharmacol Rev 75(4):789\u2013814","journal-title":"Pharmacol Rev"},{"issue":"3","key":"1667_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HCO.0000000000001038","volume":"38","author":"A Saleh","year":"2023","unstructured":"Saleh A, Al-Abcha A, Pereira N (2023) Pharmacogenetics of cardiovascular drugs. Curr Opin Cardiol 38(3):207\u2013214","journal-title":"Curr Opin Cardiol"},{"key":"1667_CR29","doi-asserted-by":"publisher","first-page":"1171047","DOI":"10.3389\/fcell.2023.1171047","volume":"11","author":"L Tao","year":"2023","unstructured":"Tao L, Cui Y, Sun J, Cao Y, Dai Z et al (2023) Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma. Front Cell Dev Biol 11:1171047","journal-title":"Front Cell Dev Biol"},{"key":"1667_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) Modeling survival data: extending the cox model. Springer"},{"issue":"6","key":"1667_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.21.01567","volume":"40","author":"AS Tsao","year":"2022","unstructured":"Tsao AS, Pass HI, Rimner A, Mansfield AS (2022) New era for malignant pleural mesothelioma: updates on therapeutic options. J Clin Oncol 40(6):681\u2013692","journal-title":"J Clin Oncol"},{"issue":"2","key":"1667_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10456-019-09688-8","volume":"23","author":"D Unterleuthner","year":"2020","unstructured":"Unterleuthner D, Neuhold P, Schwarz K, Janker L, Neuditschko B et al (2020) Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis 23(2):159\u2013177","journal-title":"Angiogenesis"},{"issue":"5","key":"1667_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1577126","volume":"8","author":"X Wang","year":"2019","unstructured":"Wang X, Li T, Cheng Y, Wang P, Yuan W et al (2019) CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation. Oncoimmunology 8(5):e1577126","journal-title":"Oncoimmunology"},{"issue":"3","key":"1667_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5853\/jos.2023.00381","volume":"25","author":"Q Wang","year":"2023","unstructured":"Wang Q, Dai H, Hou T, Hou Y, Wang T et al (2023) Dissecting causal relationships between gut microbiota, blood metabolites, and stroke: a mendelian randomization study. J Stroke 25(3):350\u2013360","journal-title":"J Stroke"},{"issue":"9","key":"1667_CR35","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrd1821","volume":"4","author":"DT Wong","year":"2005","unstructured":"Wong DT, Perry KW, Bymaster FP (2005) Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov 4(9):764\u2013774","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1667_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-021-00856-1","volume":"7","author":"W Xue","year":"2022","unstructured":"Xue W, Li X, Li W, Wang Y, Jiang C et al (2022) Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer. Signal Transduct Target Ther 7(1):35","journal-title":"Signal Transduct Target Ther"},{"key":"1667_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103034","volume":"70","author":"W Xue","year":"2024","unstructured":"Xue W, Yu Y, Yao Y, Zhou L, Huang Y et al (2024) Breast cancer cells have an increased ferroptosis risk induced by system x(c)(-) blockade after deliberately downregulating CYTL1 to mediate malignancy. Redox Biol 70:103034","journal-title":"Redox Biol"},{"issue":"18","key":"1667_CR38","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K et al (2015) DSigDB: drug signatures database for gene set analysis. Bioinformatics 31(18):3069\u20133071","journal-title":"Bioinformatics"},{"issue":"7","key":"1667_CR39","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","volume":"37","author":"S Yuan","year":"2022","unstructured":"Yuan S, Chen J, Li X, Fan R, Arsenault B et al (2022) Lifestyle and metabolic factors for nonalcoholic fatty liver disease: mendelian randomization study. Eur J Epidemiol 37(7):723\u2013733","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"1667_CR40","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman AK et al (2023) Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol 24(9):1540\u20131551","journal-title":"Nat Immunol"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-025-01667-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:03:16Z","timestamp":1760209396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-025-01667-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1667"],"URL":"https:\/\/doi.org\/10.1007\/s13258-025-01667-2","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has a relevant competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}